Cargando…
Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada
BACKGROUND: The majority of new HCV infections in Canada occur in people who inject drugs. Thus, while curative direct antiviral agents (DAAs) herald a promising new era in hepatitis C virus (HCV) treatment, improving the lives and wellbeing of people living with HCV (PLHCV) must be considered in th...
Autores principales: | Samji, Hasina, Yu, Amanda, Wong, Stanley, Wilton, James, Binka, Mawuena, Alvarez, Maria, Bartlett, Sofia, Pearce, Margo, Adu, Prince, Jeong, Dahn, Clementi, Emilia, Butt, Zahid, Buxton, Jane, Gilbert, Mark, Krajden, Mel, Janjua, Naveed Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569420/ https://www.ncbi.nlm.nih.gov/pubmed/33091735 http://dx.doi.org/10.1016/j.drugpo.2020.102989 |
Ejemplares similares
-
Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia
por: Jeong, Dahn, et al.
Publicado: (2021) -
Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019
por: Pearce, Margo E., et al.
Publicado: (2020) -
Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study
por: Pearce, Margo E., et al.
Publicado: (2021) -
Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study
por: Wilton, James, et al.
Publicado: (2020) -
The impact of COVID-19 pandemic control measures on HCV treatment initiation in British Columbia, Canada
por: Janjua, Naveed, et al.
Publicado: (2022)